Paxman AB (publ) (STO:PAX)
46.45
+0.90 (1.98%)
Apr 14, 2026, 5:29 PM CET
Paxman AB Market Cap
Paxman AB has a market cap or net worth of 1.06 billion as of April 14, 2026. Its market cap has decreased by -34.67% in one year.
Market Cap
1.06B
Enterprise Value
952.28M
Revenue
323.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
46.45
Market Cap Chart
Since June 12, 2017, Paxman AB's market cap has increased from 174.54M to 1.06B, an increase of 507.38%. That is a compound annual growth rate of 22.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 1.06B | -18.95% |
| Dec 30, 2025 | 1.31B | 4.87% |
| Dec 30, 2024 | 1.25B | 78.26% |
| Dec 29, 2023 | 699.66M | -14.62% |
| Dec 30, 2022 | 819.44M | -33.69% |
| Dec 30, 2021 | 1.24B | 203.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellaVision AB | 3.60B |
| BICO Group AB | 1.28B |
| Sedana Medical AB | 921.85M |
| C-Rad AB | 915.08M |
| Senzime AB | 719.26M |
| Bactiguard Holding AB | 588.74M |
| Q-linea AB | 416.87M |
| OssDsign AB | 387.19M |